Man Group
GILD icon

Man Group’s Gilead Sciences GILD Stock Holding History

Man Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,100
Closed -$422K – 2193
2022
Q1 		$422K Buy
+7,100
New +$454K ﹤0.01% 1639

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Man Group's GILD Position: Q1 2026 in Review

Man Group reduced its Gilead Sciences (GILD) stake by 61% in Q1 2026, selling an estimated $147M and leaving 678,066 shares worth $94.5M. The position accounts for 0.17% of the portfolio, ranked #131.

Man Group first reported a position in GILD in Q1 2018 and has held it in 30 quarters since. The position peaked at $268M in Q1 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Man Group held 678,066 shares of Gilead Sciences worth $94.5M as of Q1 2026.
  • Man Group sold 1,047,046 Gilead Sciences shares in Q1 2026, an estimated $147M.
  • Gilead Sciences made up 0.17% of Man Group's portfolio in Q1 2026, its #131 holding.
  • Man Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 30 quarters since.
  • Man Group's Gilead Sciences position peaked at $268M in Q1 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.